Family Medicine · Monterey Park, CA
NPI
1316291925
Since 2012
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
500 N Garfield Ave Ste 201
Monterey Park, CA, 91754
Phone (626) 292-5896
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.4M
59,947 services
Medicare patients, 2024
733
Average age 75
Drug cost, 2024
$7.2M
31,020 prescriptions
Company payments, 2025
$3,600
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edwin Yau was code 97140 (pt treatment), 12,762 times for 308 patients. In total Edwin Yau billed 59,947 services in 123 codes, and Medicare paid $2.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 97140 PT Treatment | Office | 12,762 | 308 | $17.17 | $219K |
| 99213 Office E&M - Established | Office | 6,903 | 638 | $76.42 | $528K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 3,345 | 536 | $52.76 | $176K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 3,170 | 537 | $40.84 | $129K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,923 | 582 | $13.48 | $39K |
| G3002 Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 2,820 | 545 | $68.78 | $194K |
| 99214 Office E&M - Established | Office | 2,759 | 594 | $106.51 | $294K |
| 97032 PT Treatment | Office | 2,465 | 283 | $9.67 | $24K |
| 97110 PT Treatment | Office | 2,041 | 414 | $21.14 | $43K |
| 99458 E&M - Miscellaneous | Office | 1,725 | 148 | $31.97 | $55K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 1,588 | 30 | $8.19 | $13K |
| 97530 PT Treatment | Office | 1,584 | 181 | $26.82 | $42K |
| J0897 Injection, denosumab, 1 mg | Office | 1,465 | 201 | $18.28 | $27K |
| 96372 Injection Administration | Office | 1,076 | 286 | $12.35 | $13K |
| 97112 PT Treatment | Office | 1,036 | 179 | $21.18 | $22K |
By year: 2022 $1.8M for 94,808 services; 2023 $2.3M for 106,297 services; 2024 $2.4M for 59,947 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 779 | 217 | $3.21 | $2,501 |
| 83036 Blood Count | 367 | 202 | $9.52 | $3,494 |
| 0241U Infectious Agent Detection by DNA/RNA | 202 | 151 | $139.78 | $28K |
Medicare prescription drug claims, 2024
In 2024, the drug Edwin Yau prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,274 prescriptions and refills. In total Edwin Yau wrote 31,020 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,274 | 2,000 | 312 | $7,193 |
| Vascepa Icosapent Ethyl | 1,149 | 1,330 | 235 | $448K |
| Losartan Potassium Generic | 1,127 | 1,660 | 238 | $5,202 |
| Rosuvastatin Calcium Generic | 1,068 | 1,459 | 230 | $5,056 |
| Montelukast Sodium Generic | 970 | 1,247 | 251 | $4,008 |
| Amlodipine Besylate Generic | 895 | 1,336 | 213 | $2,273 |
| Ezetimibe Generic | 806 | 1,091 | 162 | $8,674 |
| Metoprolol Succinate Generic | 633 | 832 | 133 | $4,011 |
| Levocetirizine Dihydrochloride Generic | 622 | 847 | 189 | $4,672 |
| Gabapentin Generic | 569 | 702 | 155 | $2,678 |
| Olmesartan Medoxomil Generic | 539 | 752 | 127 | $4,677 |
| Icosapent Ethyl Generic | 495 | 588 | 196 | $98K |
| Pantoprazole Sodium Generic | 432 | 526 | 134 | $1,738 |
| Levothyroxine Sodium Generic | 423 | 560 | 84 | $2,690 |
| Tamsulosin Hcl Generic | 391 | 567 | 95 | $2,481 |
Brand drugs: 9,239 claims; generic drugs: 21,443 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edwin Yau $3,600 ($3,600 in general payments such as food, travel and fees) from 32 companies. The largest payer was Amgen Inc. with $502.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 19 | $502 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $395 |
| Ardelyx, Inc. ARDX | 12 | $313 |
| Axsome Therapeutics, Inc. AXSM | 9 | $253 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $229 |
| GlaxoSmithKline, LLC. GSK | 10 | $223 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $196 |
| Phathom Pharmaceuticals, Inc. PHAT | 9 | $174 |
| Madrigal Pharmaceuticals MDGL | 8 | $140 |
| Genzyme Corporation SNY | 3 | $135 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.